نتایج جستجو برای: interferon alfa

تعداد نتایج: 81290  

2013
Fabio MR Barros Hugo Cheinquer Carolina T Tsuchiya Eduardo AV Santos

BACKGROUND Chronic hepatitis C affects approximately 170 million people worldwide, and thus being one of the main causes of chronic liver disease. About 20% of patients with chronic hepatitis C will develop cirrhosis over 20 years, and present an increased risk of developing hepatic complications. Sustained virological response (SVR) is associated with a better prognosis compared to untreated p...

Journal: :medical journal of islamic republic of iran 0
h. forootan digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. a. sharifi digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. sh. mirmomen digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. n. daryani digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. h. ghofrani digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. m. farahvash digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran.

abstract background: combination therapy with interferon and ribavirin is the most effective treatment for chronic hepatitis c today. the aim of this study was to evaluate the efficacy and safety of thrice-weekly heberon (interferon alfa-2b) in combination with ribavirin as first -line treatment of chronic hepatitis c. methods: a total of97 treatment-naive patients received heberon three millio...

Journal: :The Journal of infectious diseases 2010
David M Asmuth Robert L Murphy Susan L Rosenkranz Juan J L Lertora Shyam Kottilil Yoninah Cramer Ellen S Chan Robert T Schooley Charles R Rinaldo Nathan Thielman Xiao-Dong Li Sharon M Wahl Jessica Shore Jennifer Janik Richard A Lempicki Yaa Simpson Richard B Pollard

BACKGROUND To our knowledge, the antiviral activity of pegylated interferon alfa-2a has not been studied in participants with untreated human immunodeficiency virus type 1 (HIV-1) infection but without chronic hepatitis C virus (HCV) infection. METHODS Untreated HIV-1-infected volunteers without HCV infection received 180 microg of pegylated interferon alfa-2a weekly for 12 weeks. Changes in ...

2012
Kartika Widayati Taroeno-Hariadi

Peginterferon-alfa 2a or alfa 2b plus ribavirin is the treatment of choice in chronic hepatitis C. Severe adverse effects may compromise efficacy of this regiment. There are few reports of warm autoimmune hemolytic anemia following interferon-alfa or peginterferon-alfa2b plus ribavirin treatment. This present report discusses autoimmune hemolytic anemia which developed during peginterferon alfa...

Journal: :Archives of dermatology 2001
R W Dubois S M Swetter M Atkins K McMasters R Halbert S J Miller R Shiell J Kirkwood

OBJECTIVES To convene a multidisciplinary panel of dermatologists, surgical oncologists, and medical oncologists to formally review available data on the sentinel lymph node (SLN) biopsy procedure and high-dose adjuvant interferon alfa-2b therapy for patients with melanoma and to rate the "appropriateness," "inappropriateness," or "uncertainty" of the procedure and therapy to guide clinical dec...

G. Shoja-e-razavi Z. Rezaieyazdi

Background: Viral infections such as Epstein-Barr virus and Herpes simplex virus may play a role in the pathogenesis of Behçet’s disease (BD). Interferons (INF) are natural defense mechanisms against viruses and inhibit their activities by enhancing major histocompatibility complex class I and cytokine expression. This study evaluated the efficacy of INF-α-2b on mucocutaneous lesions of BD. Met...

2014
Phil McEwan Samantha Webster Yong Yuan Anupama Kalsekar Kristine Broglio Isao Kamae Melanie Quintana Masahiro Kobayashi Sachie Inoue Hiromitsu Kumada

Objectives: Japan has one of the highest endemic rates of hepatitis C virus (HCV) infection. Treatments in Japan are currently limited to interferon-alfa–based regimens, which are associated with tolerability and efficacy issues. A novel regimen combining two oral HCV therapies, daclatasvir and asunaprevir (DCV þ ASV), has shown favorable results in Japanese patients with chronic genotype 1b HC...

Journal: :Archives of dermatology 2000
V J Khanna S Shieh J Benjamin S Somach M T Zaim W Dorner M Shill G S Wood

BACKGROUND Necrolytic acral erythema is a recently described necrolytic erythema that is unique in its exclusive acral location and strong association with hepatitis C. OBSERVATION We report the first case of necrolytic acral erythema in the United States. The patient is a 43-year-old black woman who presented with a 4-year history of tender, flaccid blisters localized to the dorsal aspect of...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید